Inkjet-based 3D Bioprinting
Inkjet-based 3D Bioprinting Market Size and Growth
The Inkjet-based 3D Bioprinting market is experiencing rapid growth, driven by advancements in bioprinting technologies and increasing demand for tissue engineering applications. The market size reached approximately $200 million in 2023 and is projected to expand further, supported by rising investments in healthcare innovations and research collaborations. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ 3D Systems
◍ Organovo
◍ CELLINK
◍ Envision TEC
◍ Materialise NV
◍ Bio3D Technologies
◍ Oceanz 3D printing
◍ Solidscape
◍ Stratasys
◍ Voxeljet
The Inkjet-based 3D Bioprinting Market features key players like 3D Systems, Organovo, and CELLINK, each innovating in bioprinting technologies. These companies enhance market growth through advanced tissue engineering solutions, strategic partnerships, and expanding product portfolios. Sales figures for some include: 3D Systems (~$700 million), Stratasys (~$600 million), and Materialise (~$260 million).
Request Sample Report
Market Segmentation
By Application
Medical
Scientific Research
Other
Request Sample Report
By Product
Printing Equipment
Printing Material
Market Growth
Request Sample Report
$ X Billion USD
